The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 36, No. 7, pp. 1175-1177. DOI 10.1345/aph.1A337
© 2002 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arinzon, Z.
Right arrow Articles by Krasnyansky,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arinzon, Z.
Right arrow Articles by Krasnyansky, , II

Research Articles

Delayed recurrent SIADH associated with SSRIs

ZH Arinzon, YA Lehman, ZG Fidelman, and Krasnyansky II

BACKGROUND: Depression is a common problem in elderly patients and is frequently treated with selective serotonin-reuptake inhibitors (SSRIs). OBJECTIVE: To report a case of delayed recurrent hyponatremia after switching from one SSRI to another. CASE SUMMARY: An 87-year-old depressed woman began treatment with fluvoxamine. One week later, she was diagnosed with hyponatremia, most likely syndrome of inadequate antidiuretic hormone. Following discontinuation of fluvoxamine, the serum sodium concentration normalized. Later, she began treatment with paroxetine. Sixteen months after initiating paroxetine, she developed symptomatic recurrent hyponatremia. After paroxetine was discontinued, the sodium concentration normalized. DISCUSSION: In this case, unlike those previously reported, hyponatremia recurred 16 months after a different SSRI was initiated. The Naranjo probability scale indicates a probable relationship between recurrent hyponatremia and paroxetine. The mechanism of SSRI-induced hyponatremia is multifactorial. CONCLUSIONS: This case illustrates that replacement of one SSRI with another can cause delayed, recurrent hyponatremia in elderly patients. Plasma sodium concentrations must be monitored, not only in the first weeks of treatment, but throughout the full course.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
Z. P. Moyses, F. K. Nakandakari, and A. J. Magaldi
Fluoxetine effect on kidney water reabsorption
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1173 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. Jacob and S. A Spinler
Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults
Ann. Pharmacother., September 1, 2006; 40(9): 1618 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
Z. Bogdanovic, J. R Nalamati, J. K Kilcullen, and S. Dhuper
Antidepressant-Induced Adverse Reactions in a Patient with Hemorrhagic Stroke
Ann. Pharmacother., October 1, 2005; 39(10): 1755 - 1757.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. Vanhaesebrouck, F. De Bock, A. Zecic, C. De Praeter, K. Smets, K. De Coen, and L. Goossens
Phototherapy-Mediated Syndrome of Inappropriate Secretion of Antidiuretic Hormone in an In Utero Selective Serotonin Reuptake Inhibitor-Exposed Newborn Infant
Pediatrics, May 1, 2005; 115(5): e508 - e511.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2002 by Harvey Whitney Books Company.